Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting

Journal of Nanoparticle Research

Volumn 15, Issue 11, 2013, Pages

  Kharya, Parul ^a   Jain, Ashish ^a   Gulbake, Arvind ^a   Shilpi, Satish ^a   Jain, Ankit ^a   Hurkat, Pooja ^a   Majumdar, Subrata ^b   Jain, Sanjay K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b BOSE INSTITUTE   (India)

Author keywords

Brain cancer; Carrier mediated transport; Doxorubicin; LAT1; Nanomedicine; Nanotechnology; Phenylalanine; SLN

Indexed keywords

AMINO ACIDS; BRAIN; CELL CULTURE; CELLS; CHLORINE COMPOUNDS; CONTROLLED DRUG DELIVERY; DISEASES; EFFICIENCY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; TUMORS;

BRAIN CANCER; CARRIER-MEDIATED; DOXORUBICIN; LAT1; PHENYLALANINE;

TARGETED DRUG DELIVERY;

AMINO ACID TRANSPORTER; DOXORUBICIN; PHENYLALANINE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER CELL CULTURE; CELL MEDIATED CYTOTOXICITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG RELEASE; FEMALE; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84885501490     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2022-6     Document Type: Article

References (26)

1. Asano S, Kameyama M, Oura A, Morisato A, Sakai H, Tabuchi Y, Chairoungdua A, Endou H, Kanai Y (2007) L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa. Biolog Pharm Bull 30:415-422
2. Béduneaua A, Saulniera P, Benoita JP (2007) Active targeting of brain tumors using nanocarriers.Biomaterials 28:4947-4967
3. Behin A, H-X K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361(9354):323-331
4. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (1999) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U 21:79-84
5. Duelli R, Enerson BE, Gerhart DZ, Drewes LR (2000) Expression of large amino acid transporter LAT1 in rat brain endothelium. J Cereb Blood Flow Metab 11:1557-1562
6. Duneaua AB, Saulniera P, Benoit JP (2007) Active targeting of brain tumors using nanocarriers.Biomaterials 28:4947-4967
7. Freshney RI (1983) Culture of animal cells: a manual of basic technique. Alan R Liss, New York, p 112
8. Fundarò A, Cavallib R, Bargonic A, Vighettob D, Zaraa GP, Gascob MR (2000) Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after I V administration to rats. Pharmacol Res 42:338-342
9. Gupta Y, Jain A, Jain SK (2007) Transeferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrocholride to the brain. J Pharm Pharmacology 59:1-6
10. Jain A, Agarwal A, Majumder S, Lariya N, Khaya A, Agrawal H, Majumdar S, Agrawal GP (2010) Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Controlled Release 148(3):359-367
11. Kageyama T, Nakamura M, Matsuo A, Yamasaki Y, Takakura Y, Hashida M, Kanai Y, Naito M, Tsuruo T, Minato N, Shimohama S (2000) The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res 879:115-121
12. Kaur IP, Bhandari R, Bhandari S, Kakkar V (2008) Potential of solid lipid nanoparticles in brain targeting. J Control Rel 127:97-109
13. Lin R, Ng LS, Wang CH (2005) In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 26:4476-4485
14. Ling V (1992) P-glycoprotein and resistance to anticancer drugs. Cancer 69:2603-2609
15. Miglietta A, Cavalli R, Bocca C, Gabriel L, Gasco MR (2000) Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int J Pharm 210:61-67
16. Misra A, Ganesh S (2003) Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 6:252-273
17. Moore A, Basilion JP, Chiocca EA, Weissleder R (1998) Measuring transferring receptor gene expression by NMR imaging. Biochim Biophys Acta 1402:239-249
18. Rautio J, Laine K, (2008) Gynther M Enhanced brain drug delivery and targeting. Pharma Tech Europe
19. Reddy LH, Murthy RSR (2004) Pharmacokinetics and biodistribution studies of doxorubicin loaded poly (butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap 148:161-166
20. Reddy LH, Meda N, Murthy RSR (2005) Rapid and sensitive HPLC method for the estimation of doxorubicin in dog blood - the silver nitrate artifac. Acta Pharm 55:81-91
21. Schoepf U, Marecos E, Melder R, Jain R, Weissleder R (1998) Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 24:642
22. Schubert MA, Goymann CCM (2003) Solvent injection as a new approach for manufacturing lipid nanoparticles evaluation of the method and process parameters. Eur J Pharm Biopharm 55:125-131
23. Siekmann B, Westesen K (1994) Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol I Preparation and particle size determination. Pharm Pharmacol Lett 3:194-197
24. Storm G, Belliot SO, Daemen T, Lasic DD (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 17:31-48
25. Weissleder R, Cheng HC, Bogdanova A, Bogdanova A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7:258-263
26. Wong HL, Bendayan R, Rauth AM, Xiao YW (2004) Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J Pharm Sci 93(8):1993-2008